ATM and neoplasm: Cell free DNA (ctDNA) was assessed at the time of second intracranial disease recurrence, identifying an ATM p.L695Wfs*s alteration not detectable in the tumor specimens and with a low variant allele fraction of 0.28%, consistent with clonal hematopoiesis of indeterminate potential9.